The latest news for pharma industry insiders.
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, outlines the internal constraints that CFOs are reporting as their biggest manufacturing obstacle, along with other hurdles they are encountering.
When disasters occur, organizations such as SCAN Health Plan take a holistic approach, considering the needs of members, providers, brokers, employees and the broader community.
On today’s Big Take DC podcast: The impact Trump’s metals tariffs could have on the US economy and its relationships with some of its closest allies.
Crown Bioscience has appointed John Gu as its new Chief Executive Officer. Following his tenure as interim CEO and his role as chief operating officer, John Gu is recognized as an esteemed leader with broad business acumen and extensive experience in digital strategy, business transformation, and genomic data analysis.
Thank you
#Leadership #Insights
Cc: Elaina Shekhter Michael Wong
Have news you want us to share in Pharma Pulse? Reach out to Editor
